Enanta Pharmaceuticals Inc (ENTA)

[willyw]

I'm a long time holder but have been adding on the low price.
I was *certain* that based on generally positive data from ENTA in many of their programs that the price would start climbing. : )
- HA!! That was not in the cards today but I still added again today.

* Hep B- ENTA has a strong plan and candidates, although they are not the furthest along, they may have a basis for an all oral cure- which in a global scheme would be more desirable than w/ injectable programs.

* RSV has been increasing and if they can just complete their trials they are probably a best in class and first approval- and they have a second compound in the wings.

* Even in NASH where no one is a strong leader ENTA looks somewhat successful, and looks to have an even better 2nd gen compound.

* I have also been adding on the number of near term catalysts and a thinning of competitors in many programs.

* Covid is not going away and continues to mutate. An effective anti-viral oral agent could attract Govt funding and accelerated approval.

* Note that ABBV and ENTA were not first in HCV but in the end were FIRST IN CLASS with the most effective and shortest treatment. Gilead was a close second BUT they didn't create their nuke; they bought it in Phase 3.
A G/P pediatric approval just happened in kids 3 years and older.
HCV acute cases also increased 14% 2018-2019.

* Anyone that has held ENTA has seen periods of volatility; both down and upwards- for me a better time to add than to sell.

Above are a few reasons I added today.